Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety and efficacy of intracoronary bivalirudin administration during primary angioplasty in comparison with a standard treatment with heparin and provisional GP2b3a inhibitors

Autor: Lupi, A, Secco, Gg, Rognoni, A, Porto, I, Lazzero, M, Bongo, As

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3710::2742017af93f6a1495f6b58c5ddff621
https://hdl.handle.net/11567/937221

P252 THE TREATMENT WITH BETA–BLOCKERS AFTER MYOCARDIAL INFARCTION WITHOUT REDUCED EJECTION FRACTION (REBOOT) TRIAL, 2023 UPDATES

Autor: Bianco, M, Lazzero, M, Agnelli, N, Staszewsky, L, Pellizzoni, V, Vasami‘, A, Ferraro, S, Latini, R, Chinaglia, A

Publikováno v: European Heart Journal Supplements: Journal of the European Society of Cardiology; May 2023, Vol. 25 Issue: 1, Number 1 Supplement 4 pD137-D138, 2p

Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients

Autor: Lupi, A, Navarese, EP, Lazzero, M, Sansa, M, De Servi, S, Serra, A, Bongo, AS, Buffon, A

Publikováno v: CIRCULATION JOURNAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Background: Evidence supporting the use of drug-eluting stents (DES) in saphenous vein graft (SVG) disease is uncertain. Previous studies have suggested that DES might reduce the re-intervention rate in SVG disease, with conflicting data on mortality

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::556826799625dae7652b97e095f05f9f
http://hdl.handle.net/10807/57499

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.